Oncology Institute Dividends
| TOI Stock | USD 2.61 0.16 6.53% |
The current Dividends Paid is estimated to decrease to 0.86. The current Dividend Yield is estimated to decrease to 0.01. Oncology Institute's past performance could be the main factor of why investors trade Oncology Institute stock today. Investors should clearly understand every aspect of the Oncology Institute dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Oncology Institute's dividend schedule and payout information. Oncology Institute dividends can also provide a clue to the current valuation of Oncology Institute.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 0.90 | 0.86 | |
| Dividend Yield | 0.01 | 0.01 | |
| Dividend Payout Ratio | 1.87 | 1.66 | |
| Dividend Paid And Capex Coverage Ratio | (8.05) | (8.46) |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Oncology Institute must own a stock before its ex-dividend date to receive its next dividend.
Oncology Institute Dividends Paid Over Time
Today, most investors in Oncology Institute Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Oncology Institute's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Oncology Institute dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Oncology Institute Historical Dividend Yield Growth
A solid dividend growth pattern of Oncology Institute could indicate future dividend growth is likely, which can signal long-term profitability for Oncology Institute. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Oncology Institute dividend as a percentage of Oncology Institute stock price. Oncology Institute dividend yield is a measure of Oncology Institute stock productivity, which can be interpreted as interest rate earned on an Oncology Institute investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Is there potential for Health Care Equipment & Supplies market expansion? Will Oncology introduce new products? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.67) | Revenue Per Share | Quarterly Revenue Growth 0.215 | Return On Assets | Return On Equity |
Investors evaluate Oncology Institute using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Oncology Institute's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Oncology Institute's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Oncology Institute's market price signifies the transaction level at which participants voluntarily complete trades.